FIELD: biotechnology.
SUBSTANCE: peptide exhibiting the enzymatic activity of beta-galactosidase. The invention relates to the use of a peptide exhibiting beta-galactosidase enzymatic activity for the production of a lactose-reduced dairy product.
EFFECT: using the enzyme in a wide temperature and pH range for effective lactose reduction.
14 cl, 16 dwg, 2 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LACTASE ENZYMES WITH IMPROVED PROPERTIES | 2018 |
|
RU2788608C2 |
| LACTASE ENZYMES WITH IMPROVED ACTIVITY AT LOW TEMPERATURES | 2018 |
|
RU2800427C2 |
| LACTASE ENZYMES WITH IMPROVED PROPERTIES AT ACIDIC pH | 2019 |
|
RU2814542C2 |
| METHODS OF IMPROVING PLANTS' HEALTH WITH APPLICATION OF FREE ENZYMES AND MICROORGANISMS EXPRESSING ENZYMES AT ELEVATED LEVEL | 2017 |
|
RU2802848C2 |
| ABC TRANSPORTERS FOR HIGHLY EFFICIENT PRODUCTION OF REBAUDIOSIDES | 2020 |
|
RU2795855C2 |
| FUSED MOLECULES DERIVED FROM CHOLIX-TOXIN FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE LOADS | 2015 |
|
RU2723178C2 |
| PREPARATION CONTAINING VIII FACTOR AND VON WILLEBRAND FACTOR PEPTIDES | 2015 |
|
RU2714154C2 |
| COMPOSITIONS AND METHODS FOR DEGRADATION OF IMPROPERLY PACKAGED PROTEINS | 2016 |
|
RU2761564C2 |
| PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PRODUCTION | 2020 |
|
RU2795973C1 |
| PHARMACEUTICAL COMPOSITION AND METHOD OF PREVENTION AND TREATMENT OF LYSOSOMAL ENZYME DEFICIENCY IN SUBJECT WITH TYPE II MUCOPOLYSACCHARIDOSIS | 2023 |
|
RU2814280C1 |
